Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
4(40%)
Results Posted
50%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_4
1
10%
Ph not_applicable
7
70%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(4)
Terminated(2)

Detailed Status

Completed4
Active, not recruiting2
Recruiting2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 41 (11.1%)
N/A7 (77.8%)

Trials by Status

completed440%
terminated110%
withdrawn110%
active_not_recruiting220%
recruiting220%

Recent Activity

4 active trials
Showing 5 of 10
active_not_recruitingnot_applicable

AJYR+GV vs RYGB for GERD

NCT07768202
active_not_recruitingnot_applicable

Sleeve Gastrectomy With Transit Bipartition(SG+TB) Versus Roux-en-Y Gastric Bypass (RYGB) for Type 3 Obesity

NCT04915014
completednot_applicable

Cerebrospinal Fluid Biomarkers in Bariatric Surgery

NCT04350892
recruitingnot_applicable

Comparison of Nissen-Sleeve and Gastric Bypass for GERD in Obese Patients

NCT07158008
withdrawnnot_applicable

Management of Symptomatic Gastric Sleeve Stenosis After Laparoscopic Sleeve Gastrectomy

NCT04781946
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07768202Not Applicable

AJYR+GV vs RYGB for GERD

Active Not Recruiting
NCT04915014Not Applicable

Sleeve Gastrectomy With Transit Bipartition(SG+TB) Versus Roux-en-Y Gastric Bypass (RYGB) for Type 3 Obesity

Active Not Recruiting
NCT04350892Not Applicable

Cerebrospinal Fluid Biomarkers in Bariatric Surgery

Completed
NCT07158008Not Applicable

Comparison of Nissen-Sleeve and Gastric Bypass for GERD in Obese Patients

Recruiting
NCT04781946Not Applicable

Management of Symptomatic Gastric Sleeve Stenosis After Laparoscopic Sleeve Gastrectomy

Withdrawn
NCT03842475

Who Will Benefit From Bariatric Surgery for Diabetes?

Recruiting
NCT02041234Phase 4

Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment

Completed
NCT02762708Phase 2

The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes

Completed
NCT02144597Not Applicable

Low-calorie Diet and Body Composition Prior to Roux-en-Y Gastric Bypass

Completed
NCT00580762Not Applicable

Bariatric Surgery for ESRD Patients vs Control

Terminated

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10